- Home
- ASLE vs KMDA Comparison
ASLE vs KMDA Comparison
Compare ASLE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- KMDA
- Stock Information
- Founded
- ASLE 2008
- KMDA 1990
- Country
- ASLE United States
- KMDA Israel
- Employees
- ASLE N/A
- KMDA N/A
- Industry
- ASLE Industrial Specialties
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- ASLE Consumer Discretionary
- KMDA Health Care
- Exchange
- ASLE Nasdaq
- KMDA Nasdaq
- Market Cap
- ASLE 375.1M
- KMDA 398.5M
- IPO Year
- ASLE N/A
- KMDA N/A
- Fundamental
- Price
- ASLE $7.42
- KMDA $6.92
- Analyst Decision
- ASLE Hold
- KMDA Strong Buy
- Analyst Count
- ASLE 2
- KMDA 2
- Target Price
- ASLE $7.50
- KMDA $13.00
- AVG Volume (30 Days)
- ASLE 365.9K
- KMDA 77.7K
- Earning Date
- ASLE 11-06-2025
- KMDA 11-12-2025
- Dividend Yield
- ASLE N/A
- KMDA 2.89%
- EPS Growth
- ASLE N/A
- KMDA 27.97
- EPS
- ASLE 0.13
- KMDA 0.32
- Revenue
- ASLE $350,583,000.00
- KMDA $169,517,000.00
- Revenue This Year
- ASLE $9.98
- KMDA $14.49
- Revenue Next Year
- ASLE $8.15
- KMDA $10.12
- P/E Ratio
- ASLE $58.60
- KMDA $21.22
- Revenue Growth
- ASLE N/A
- KMDA 9.67
- 52 Week Low
- ASLE $5.16
- KMDA $5.54
- 52 Week High
- ASLE $9.12
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- ASLE 41.66
- KMDA 51.41
- Support Level
- ASLE $7.34
- KMDA $6.82
- Resistance Level
- ASLE $7.66
- KMDA $7.11
- Average True Range (ATR)
- ASLE 0.26
- KMDA 0.19
- MACD
- ASLE 0.00
- KMDA 0.02
- Stochastic Oscillator
- ASLE 25.86
- KMDA 55.56
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.